198 related articles for article (PubMed ID: 32831048)
1. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
Muratov S; Canelo-Aybar C; Tarride JE; Alonso-Coello P; Dimitrova N; Borisch B; Castells X; Duffy SW; Fitzpatrick P; Follmann M; Giordano L; Hofvind S; Lebeau A; Quinn C; Torresin A; Vialli C; Siesling S; Ponti A; Giorgi Rossi P; Schünemann H; Nyström L; Broeders M;
BMC Cancer; 2020 Aug; 20(1):795. PubMed ID: 32831048
[TBL] [Abstract][Full Text] [Related]
2. Time trends of process and impact indicators in Italian mammography screening programmes--1996-2004.
Giordano L; Giorgi D; Piccini P; Ventura L; Stefanini V; Senore C; Paci E; Segnan N
Epidemiol Prev; 2007; 31(2-3 Suppl 2):21-32. PubMed ID: 17824360
[TBL] [Abstract][Full Text] [Related]
3. National Breast Cancer Screening Programme, Singapore: evaluation of participation and performance indicators.
Loy EY; Molinar D; Chow KY; Fock C
J Med Screen; 2015 Dec; 22(4):194-200. PubMed ID: 26081449
[TBL] [Abstract][Full Text] [Related]
4. Participation rate or informed choice? Rethinking the European key performance indicators for mammography screening.
Strech D
Health Policy; 2014 Mar; 115(1):100-3. PubMed ID: 24332817
[TBL] [Abstract][Full Text] [Related]
5. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program.
Hofvind S; Geller B; Vacek PM; Thoresen S; Skaane P
Eur J Epidemiol; 2007; 22(7):447-55. PubMed ID: 17594526
[TBL] [Abstract][Full Text] [Related]
6. [The effectiveness of population-based breast cancer screening programme].
Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
[TBL] [Abstract][Full Text] [Related]
7. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Vreemann S; Gubern-Mérida A; Schlooz-Vries MS; Bult P; van Gils CH; Hoogerbrugge N; Karssemeijer N; Mann RM
Radiology; 2018 Feb; 286(2):443-451. PubMed ID: 29040037
[TBL] [Abstract][Full Text] [Related]
8. Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.
Bento MJ; Gonçalves G; Aguiar A; Castro C; Veloso V; Rodrigues V
Cancer Epidemiol; 2015 Oct; 39(5):783-9. PubMed ID: 26315486
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme.
Majek O; Danes J; Skovajsova M; Bartonkova H; Buresova L; Klimes D; Brabec P; Kozeny P; Dusek L
BMC Public Health; 2011 May; 11():288. PubMed ID: 21554747
[TBL] [Abstract][Full Text] [Related]
10. Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
Herrmann C; Morant R; Walser E; Mousavi M; Thürlimann B
BMC Cancer; 2021 Mar; 21(1):229. PubMed ID: 33676446
[TBL] [Abstract][Full Text] [Related]
11. National Health Service breast screening programme results for 1991-2.
Chamberlain J; Moss SM; Kirkpatrick AE; Michell M; Johns L
BMJ; 1993 Aug; 307(6900):353-6. PubMed ID: 8374416
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
Sebuødegård S; Botteri E; Hofvind S
J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
[TBL] [Abstract][Full Text] [Related]
13. [Time trends of process and impact indicators in Italian breast screening programmes (2000-2010)].
Giordano L; Giorgi D; Ventura L; Castagno R; Paci E; Segnan N
Epidemiol Prev; 2012; 36(6 Suppl 1):28-38. PubMed ID: 23293269
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Screening in Morocco: Performance Indicators During Two Years of an Organized Programme.
El Fakir S; Najdi A; Khazraji YC; Bennani M; Belakhel L; Abousselham L; Lyoussi B; Bekkali R; Nejjari C
Asian Pac J Cancer Prev; 2015; 16(15):6285-8. PubMed ID: 26434830
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the significance of population-based breast cancer screening among women aged under 40 years.
Okazaki M; Bando H; Tohno E; Kujiraoka Y; Iguchi-Manaka A; Ichioka E; Tsushima Y; Watanabe H; Hara H
Breast Cancer; 2021 Jan; 28(1):75-81. PubMed ID: 32643018
[TBL] [Abstract][Full Text] [Related]
16. Validity of process indicators of screening for breast cancer to predict mortality reduction.
Sarkeala T; Anttila A; Saarenmaa I; Hakama M
J Med Screen; 2005; 12(1):33-7. PubMed ID: 15814017
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance.
Basu P; Selmouni F; Belakhel L; Sauvaget C; Abousselham L; Lucas E; Muwonge R; Sankaranarayanan R; Khazraji YC
Int J Cancer; 2018 Dec; 143(12):3273-3280. PubMed ID: 30006933
[TBL] [Abstract][Full Text] [Related]
18. ["European Commission Initiative on Breast Cancer": Selected Breast Cancer Screening Recommendations from the European Guidelines.].
Saz-Parkinson Z; Monteagudo-Piqueras O; Granados Ortega J; Martínez Mondéjar E; Labrador Cañadas MV
Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33323925
[TBL] [Abstract][Full Text] [Related]
19. Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.
Bernardi D; Gentilini MA; De Nisi M; Pellegrini M; Fantò C; Valentini M; Sabatino V; Luparia A; Houssami N
Breast; 2020 Apr; 50():135-140. PubMed ID: 31607526
[TBL] [Abstract][Full Text] [Related]
20. Influence of service characteristics on high priority performance indicators and standards in the BreastScreen Australia program.
Roder DM; Ward GH; Farshid G; Gill PG;
Asian Pac J Cancer Prev; 2014; 15(14):5901-8. PubMed ID: 25081720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
